Minocycline Eg (Minocycline Hydrochloride Dihydrate)

Minocycline Hydrochloride Dihydrate, the active ingredient in Minocycline Eg, is a tetracycline antibiotic presented as an oral tablet for systemic use. It is employed to treat bacterial infections such as acne vulgaris, respiratory tract infections, and skin and soft‑tissue infections in adult patients, providing an oral antibacterial option.

GNH USA supplies Minocycline Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU GMP standards and providing reliable global distribution. The company ensures batch‑to‑batch consistency and supports regulatory compliance for importers.

Minocycline is a tetracycline antibiotic used to manage bacterial infections affecting the skin, respiratory system, and related tissues. - Acne vulgaris: reduces inflammatory lesions and bacterial colonisation, improving skin appearance in moderate to severe cases. - Respiratory tract infections: treats community‑acquired pneumonia, bronchitis and sinusitis caused by susceptible organisms, providing oral antibacterial coverage. - Skin and soft tissue infections: combats cellulitis, abscesses and wound infections by targeting Gram‑positive and Gram‑negative bacteria, facilitating healing.

Minocycline may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, sometimes with abdominal cramping. - Dizziness or vertigo: transient balance disturbances. - Photosensitivity: increased skin sensitivity to sunlight. - Skin discoloration: blue‑gray pigmentation of the skin or nails.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or jaundice. - Lupus‑like syndrome: arthralgia, fever and serologic abnormalities. - Severe allergic reactions: anaphylaxis, Stevens‑Johnson syndrome or toxic epidermal necrolysis.

When prescribing Minocycline, clinicians should consider several safety precautions to minimise risks. - Renal or hepatic impairment: assess function before initiating therapy. - Age restrictions: avoid use in children under 8 years due to tooth discoloration risk. - Pregnancy and lactation: use only if clearly needed, after evaluating benefits versus risks. - Concomitant isotretinoin: avoid combined use because of increased intracranial hypertension risk. - Sun exposure: advise patients to use sunscreen and protective clothing. - Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Minocycline can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Isotretinoin: combined use may increase risk of intracranial hypertension. - Oral contraceptives: may reduce hormonal efficacy, increasing risk of unintended pregnancy. - Anticoagulants (warfarin): enhanced anticoagulant effect, requiring close monitoring.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: decrease minocycline absorption; separate dosing by at least 2 hours. - Penicillins: antagonistic antibacterial activity may reduce therapeutic effect. - Barbiturates and carbamazepine: increase hepatic metabolism, potentially lowering minocycline levels.